Dachaigh › Tumor neuroendocrine gastro-enteropancreatic
Sgrùdaidhean clionaigeach Tumor neuroendocrine gastro-enteropancreatic a’ fastadh anns na SA
Tha 7 sgrùdaidhean airson Tumor neuroendocrine gastro-enteropancreatic a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
Le stàit
- Florida3 sgrùdaidhean
- Kentucky3 sgrùdaidhean
- Ohio3 sgrùdaidhean
- Tennessee3 sgrùdaidhean
- Texas3 sgrùdaidhean
- Virginia3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
A’ fastadhÌre 1
24 Months – 18 Years · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06441331Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07165132Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
A’ fastadhÌre 3
Aoisean 12 gu 100 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06784752A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT07635316Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
A’ fastadhÌre 1/2
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT05636618Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Màrt 2026 · NCT04090034Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT07150546Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.